Silent liver diseases in autopsies from forensic medicine of Tehran

Archives of Iranian Medicine

Volumn 9, Issue 4, 2006, Pages 324-328

  Sotoudehmanesh, Rasoul ^a   Sotoudeh, Masoud ^a   Ali Asgari, Ali ^a   Abedi Ardakani, Behnoush ^a   Tavangar, Seyed Mohammad ^a   Khakinejad, Ali ^a   Sadeghi, Zohreh ^a   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autopsy; Liver disease; Steatohepatitis

Indexed keywords

EOSIN; HEMATOXYLIN; OPIATE; RETICULIN;

ACUTE HEART INFARCTION; ADULT; ANAMNESIS; ARTICLE; AUTOPSY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC HEPATITIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG OVERDOSE; FATTY LIVER; FEMALE; FORENSIC MEDICINE; HISTOPATHOLOGY; HUMAN; INFECTION; INJURY; IRAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER STRUCTURE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; TISSUE SECTION;

ADULT; AUTOPSY; CAUSE OF DEATH; FEMALE; FORENSIC MEDICINE; HUMANS; INFLAMMATION; IRAN; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; TIME FACTORS;

EID: 33751318292     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Voinova LV. Etiological and nosological structure of liver diseases (on autopsy data of clinics of I.M. Sechenov Moscow Medical Academy in 1988-1997). Arkh Patol. 2000; 62: 45-47.
2. Berry CL. Liver lesions in an autopsy population. Hum Toxicol. 1987; 6: 209-214.
3. Lee YS. The pattern of liver diseases in Singapore. An autopsy study. Trop Geogr Med. 1979; 31: 69-74.
4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346: 1221-1231.
5. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001; 21: 17-26.
6. Propst A, Propst T, Judmaier G, Vogel W. Prognosis in nonalcoholic steatohepatitis. Gastroenterology. 1995; 108: 1607.
7. Hultcrantz R, Glaumann H, Lindberg G, Nilsson LH. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol. 1986; 21: 109-113.
8. Nonomura A, Mizukami Y, Unoura M, Kobayashi K, Takeda Y, Takeda R. Clinicopathologic study of alcohol-like liver disease in nonalcoholics; nonalcoholic steatohepatitis and fibrosis. Gastroenterol Jpn. 1992; 27: 521-528.
9. Hilden M, Christoffersen P, Juhl E, Dalgaard JB. Liver histology in a 'normal' population - examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol. 1977; 12: 593-597.
10. Malekzadeh R, Nasseri-Moghaddam S, Sotoudeh M. Gastroesophageal reflux disease: the new epidemic. Arch Iranian Med. 2003; 6: 127-140.
11. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999; 29: 664-669.
12. Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier MH, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 2002; 35: 1485-1493.
13. Kochar N, Lowes J, Teague RH. Nonalcoholic fatty liver disease (NAFLD) in South West England. Gastroenterology. 2002; 122: A-669.
14. Azimi K, Sarafi M, Alavian SM, Alawi M, Mikaeli J, Malekzadeh R. Causes of cirrhosis in cirrhotic patients in Shariati Hospital. Govaresh. 2002; 37: 19-26.
15. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iranian Med. 2000; 3: 192-201.
16. Shakoori A. Silent chronic hepatitis in forensic medicine [in Persian]. Pezeshki Ghanooni. 1994; 1: 52-58.
17. Bethke BA, Schubert GE. Primary hepatic cancer and liver cirrhosis. Hepatogastroenterology. 1984; 31; 211-214.
18. Zotti S, Piccigallo E, Rampinelli L, Romagnoli G, Tufano A, Dagnini G. Primary and metastatic tumors of the liver associated with cirrhosis: a study based on laparoscopy and autopsy. Gastrointest Endosc. 1986; 32: 91-95.
19. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology. 1995; 22: 1027-1033.
20. Poovorawn Y, Sripattanawatb R, Theamboonlers A, Chongsrisawat V, Nuchprayoon I. Hepatocellular carcinoma: significance of HBV vertical transmission. Asian Pac J Allergy Immunol. 1998; 16: 93-103.
21. Zumla A, James DG. Granulomatous infections: etiology and classification. Clin Infect Dis. 1996; 23: 146-158.
22. Ishak KG. Granulomas of the liver. Adv Pathol Lab Med. 1995; 8: 247-261.
23. Cunnigham D, Mills PR, Quigley EM, Patrick RS, Watkinson G, MacKenzie JF, et al. Hepatic granulomas: experience over a 10-year period in the West of Scotland. Q J Med. 1982; 51: 162-170.
24. Klatskin G. Hepatic granulomata: problems in interpretation. Mt Sinai J Med. 1977; 44: 798-812.
25. Nakanuma Y. Nodular regenerative hyperplasia of the liver: restrospective survey in autopsy series. J Clin Gastroenterol. 1990; 12: 460-465.
26. Wanless IR. Understanding noncirrhotic portal hypertension. Hepatology. 1988; 8: 192-193.
27. Wanless IR. The use of morphometry in the study of nodular regenerative and vascular lesions of the liver. Anal Quant Cytol Histol. 1987; 9: 39-41.